Jeff Ubben’s Wall Street Journal Op-Ed


Corporate America is stuck in a rut, and it is holding back economic growth. Despite record-low financing costs, capital-expenditure plans at large firms are down, R&D is being cut, and mergers and acquisitions are at a virtual standstill. This corporate age of austerity is a failure of governance—not just in Washington but in public company boardrooms.

In the name of risk management, corporate boards have lost the “owner” mentality they need in designing management compensation. Too many CEOs are now better off being caretakers instead of value creators. Surprisingly, the solution may entail more compensation for CEOs, not less—but only …Read the rest on WSJ

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!